Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FLAVONOIDS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FLAVONOIDS is a concept in neurodegeneration research. Key relationships include: therapeutic target, activates, regulates. Associated with ALS, Aging, Als. Connected to 283 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | FLAVONOIDS |
| Key Genes/Proteins | ACHE, AGING, AKT, AKT1, Albumin, ALZHEIMER |
| Related Diseases | Aging, Als, ALS, Alzheimer, Alzheimer'S Disease |
| Related Pathways | Akt |
graph TD
FLAVONOIDS["FLAVONOIDS"]
FLAVONOIDS -->|"regulates"| ERK["ERK"]
FLAVONOIDS -.protects against.-> oxidative_stress["oxidative stress"]
FLAVONOIDS -.protects against.-> chronic_inflammation["chronic inflammation"]
FLAVONOIDS -->|"regulates"| BCL2["BCL2"]
FLAVONOIDS -->|"activates"| apoptosis["apoptosis"]
FLAVONOIDS -->|"regulates"| IL_1_["IL-1beta"]
FLAVONOIDS -->|"regulates"| TNF__["TNF-alpha"]
FLAVONOIDS -->|"inhibits"| Tau_protein_aggregation["Tau protein aggregation"]
AGING["AGING"] -->|"target for"| FLAVONOIDS
BDNF["BDNF"] -->|"activates"| FLAVONOIDS
ERK -->|"activates"| FLAVONOIDS
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"target for"| FLAVONOIDS
MICROGLIA["MICROGLIA"] -->|"target for"| FLAVONOIDS
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| FLAVONOIDS
HK2["HK2"] -->|"activates"| FLAVONOIDS
AMPK["AMPK"] -->|"activates"| FLAVONOIDS
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| FLAVONOIDS| Target | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | protects_against | disease | 0.90 |
| Oxidative Stress | inhibits | process | 0.90 |
| Inflammation | inhibits | process | 0.85 |
| Alzheimer's Disease | protects_against | disease | 0.85 |
| Cancer | therapeutic_target | disease | 0.85 |
| APOPTOSIS | inhibits | process | 0.85 |
| INFLAMMATION | inhibits | process | 0.85 |
| OXIDATIVE STRESS | inhibits | process | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Neurodegeneration | therapeutic_target | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Als | regulates | disease | 0.85 |
| TAU | inhibits | protein | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| NF-κB | modulates | pathway | 0.85 |
| MAPT | inhibits | protein | 0.85 |
| Aging | treats | disease | 0.85 |
| Mitochondrial Function | associated_with | process | 0.80 |
| ERK | regulates | gene | 0.80 |
| Apoptosis | inhibits | process | 0.80 |
| MAPK | modulates | pathway | 0.80 |
| PI3K | modulates | gene | 0.80 |
| PI3K/Akt | modulates | pathway | 0.80 |
| Apoptosis | therapeutic_target | pathway | 0.80 |
| Fibrosis | inhibits | disease | 0.75 |
| Inflammation | inhibits | disease | 0.75 |
| Neuroinflammation | therapeutic_target | disease | 0.75 |
| Ischemia | therapeutic_target | disease | 0.75 |
| Cardiovascular | treats | disease | 0.75 |
| Neuroinflammation | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Tumor | regulates | disease | 0.75 |
| Neurodegenerative Diseases | treats | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Parkinson | therapeutic_target | disease | 0.75 |
| Autophagy | regulates | process | 0.75 |
| AKT | modulates | protein | 0.75 |
| ERK | modulates | protein | 0.75 |
| NFKB | modulates | protein | 0.75 |
| Oxidative Stress | therapeutic_target | pathway | 0.70 |
| Nf-Κb | regulates | pathway | 0.70 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.70 |
| Glucose Metabolic Reprogramming | modulates | process | 0.70 |
| TNF-α | regulates | protein | 0.70 |
| Akt | regulates | protein | 0.70 |
| oxidative stress | protects_against | process | 0.70 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.70 |
| apoptosis | inhibits | process | 0.70 |
| apoptosis | activates | process | 0.70 |
| IL-1β | regulates | protein | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| OXIDATIVE STRESS | associated_with | gene | 0.70 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.70 |
| NF-ΚB | regulates | gene | 0.70 |
| AKT | treats | gene | 0.70 |
| AMPK | therapeutic_target | gene | 0.70 |
| NEURODEGENERATION | therapeutic_target | gene | 0.70 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.70 |
| NFKB | inhibits | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| IL-1 | inhibits | gene | 0.60 |
| GLUT3 | inhibits | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| IL-4 | activates | gene | 0.60 |
| TNF | inhibits | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| MICROGLIA ACTIVATION | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| AGING | treats | gene | 0.60 |
| ERK | inhibits | gene | 0.60 |
| ALZHEIMER | protects_against | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.60 |
| ALS | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| HUNTINGTON | therapeutic_target | gene | 0.60 |
| HUNTINGTON | protects_against | gene | 0.60 |
| ALZHEIMER'S DISEASE | protects_against | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| TNF | regulates | gene | 0.60 |
| IL-6 | regulates | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| TLR | regulates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| TNF-Α | regulates | gene | 0.60 |
| HK2 | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | regulates | gene | 0.60 |
| PARKINSON'S DISEASE | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| NRF2 | regulates | gene | 0.60 |
| AKT | regulates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning FLAVONOIDS in their description or question text
No additional research found